| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2005-10-17^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-01-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78ebf5312c3689af6c786914f7520a90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c243b2759c7ad9bf76036d97adf60be8 |
| publicationDate |
2012-01-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2373044-T3 |
| titleOfInvention |
PROCEDURES AND COMPOSITIONS TO PREACH THE RESPONSE TO WARFARINA. |
| abstract |
A method for determining an optimal warfarin dose for a human subject, said procedure comprising: determining, in a nucleic acid molecule corresponding to SEQ ID NO: 1, which is from a sample obtained from a human subject, the genotype in the nucleotide positions 381 and / or 3673; and identify the optimal warfarin dose for the subject based on said determination. |
| priorityDate |
2004-10-18^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |